Advance SMS Research in 2025

As this year comes to a close, we invite you to support an exciting opportunity in Smith-Magenis Syndrome research for 2025. The SMS Research Foundation is preparing to fund “Developing a Safe, Dosage-Controlled Gene Therapy for Reversing SMS”—a groundbreaking collaboration between McGill University and Stanford University, two world-class labs working together to advance treatments for SMS.

Help us reach our goal of $162,000 to fully fund this project. Every gift brings us closer to a life-changing treatment for SMS.

You can also send donations by check to:

SMS Research Foundation
P.O. Box 661
Georgetown, CT 06829-0661

Tax ID: #27-2906662

Tel: (203) 544-4418‬‬